covid
Buscar en
Infectio
Toda la web
Inicio Infectio Evaluación del impacto de un programa de vigilancia epidemiológica del consumo...
Journal Information
Vol. 13. Issue 1.
Pages 6-13 (March 2009)
Share
Share
Download PDF
More article options
Vol. 13. Issue 1.
Pages 6-13 (March 2009)
Open Access
Evaluación del impacto de un programa de vigilancia epidemiológica del consumo de antibióticos y la flora en una clínica de tercer nivel
Evaluation of the impact of a program of epidemiological surveillance in consumption of antibiotics and flora in a third level clinic
Visits
1810
Juan Carlos Cataño1, Omar Castaño1,
Corresponding author
omarcastaq@hotmail.com

Calle 2 sur N° 46-55 (319), Medellín, Colombia. Teléfono: 266 8737.
1 Clínica Las Vegas, Medellín
This item has received

Under a Creative Commons license
Article information
Resumen
Objetivo

Evaluar el impacto que un programa de vigilancia epidemiológica tiene en las características de la formulación de antibióticos y la frecuencia de gérmenes multirresistentes en una clínica de tercer nivel en la ciudad de Medellín.

Materiales y métodos

Es un estudio retrospectivo y observacional, dividido en una fase de 18 meses previa a la intervención, comprendida entre julio 1 de 2004 y diciembre 31 de 2005, y una fase de intervención de 18 meses, comprendida entre enero 1 de 2006 y junio 30 de 2007.

El estudio se llevó a cabo en la Clínica Las Vegas de la ciudad de Medellín. Incluyó como universo, los aislamientos de gérmenes multirresistentes y la cantidad de antibiótico formulado. Se evaluaron los cambios en la formulación de antibióticos (dosis diaria definida por 100 día/cama) y los cambios en la frecuencia de aislamientos de gérmenes multirresistentes.

Resultados

Se encontró un incremento progresivo en el uso de antibióticos, sin que se hubieran modificado los indicadores de ocupación hospitalaria. La política de intervención demostró una reducción estadísticamente significativa en el uso de ceftriaxona (p<0,001), imipenem (p<0,01), meropenem (p<0,001) y glucopéptidos (p<0,04), asociada a un aumento en la formulación de ampicilina/sulbactam, piperacilina/tazobactam, quinolonas y aminoglucósidos. No se modificó la frecuencia de aislamientos de gérmenes multirresistentes (p<0,51).

Conclusiones

Una política de vigilancia epidemiológica tiene un impacto positivo en el consumo general de antibióticos de gran valor biológico y económico, sin que el presente estudio haya podido demostrar un impacto positivo en la frecuencia de aislamientos multirresistentes.

Palabras clave:
bacterias
antibióticos
vigilancia epidemiológica
dosificación
resistencia
aislamiento
Abstract
Objective

To determine the impact of an epidemiological surveillance program in the formulation patterns of antimicrobials, and the frequency of multirresistant bacteria isolated in a third level clinic in Medellin.

Materials and methods

A retrospective and observational study, divided in a pre-intervention phase of 18 months, between July 1st 2004 a December 31st 2005, and an intervention phase of 18 months, between January 1st 2006 and June 30th 2007 was carried out. The study was done at Las Vegas Clinic in Medellín on the multiresistant bacteria isolated and the amount of antibiotic prescribed. The observed changes were evaluated in the magnitude of antibiotics formulation (daily defined doses x 100 day-bed) and the changes in the frequency of isolations of multiresistant bacteria.

Results

A progressive increase in the use of antibiotics was found without modifying clinic occupation indicators, the intervention policy demonstrated statistically significant reduction in the use of Ceftriaxone (p<0.001), Imipenem (p 0.01), Meropenem (p<0.001) and glicopeptides (p 0.04), this was associated with an increase in the Ampicillin/Sulbactam, Piperacillin/Tazobactam, quinolones and aminoglicosides formulation. It did not modify the frequency of evaluated multiresistant germs (p 0.51).

Conclusions

An epidemiologic surveillance policy has a positive impact in antibiotic consumption, but this study does not demonstrate a positive impact in multiresistant bacteria isolation frequency.

Key words:
bacteria
resistance
antibacterial agents
surveillance
isolation
epidemiologic
Full text is only aviable in PDF
Bibliografía
[1.]
M. Rekha.
Implementation of strategies to control antimicrobial resistance.
Chest, 119 (2001), pp. 405S-411S
[2.]
M.N. Swartz.
Use of antimicrobial agents and drug resistance.
N Engl J Med, 337 (1997), pp. 491-492
[3.]
S.B. Levy.
Multidrug resistance-A sign of the times.
N Engl J Med, 338 (1998), pp. 1376-1378
[4.]
S. Nseir, C. Di Pompeo, S. Soubrier, P. Delour, H. Lenci, M. Roussel-Delvallez.
First generation fluroquinolonas use and subsequent emergence of multiple drug-resistant bacteria in the intense care unit.
Crit Care Med, 33 (2005), pp. 283-289
[5.]
D.M. Shlaes, D.N. Gerding, J.F. John Jr., W.A. Craig, D.L. Bornstein, R.A. Duncan, et al.
Society for healthcare epidemiology of America joint committee on the prevention of antimicrobial resistance: Guidelines for the prevention of antimicrobial resistance in the hospitals.
Clin Infect Dis, 25 (1997), pp. 584-599
[6.]
D.A. Goldmann, R.A. Weinstein, R.P. Wenzel, O.C. Tablan, R.J. Duma, R.P. Gaynes.
Strategies to prevent and control the emergence and spread of antimicrobial resistant microorganism in hospitals: A challenge to hospital leaderships.
JAMA, 275 (1996), pp. 234-240
[7.]
J.P. Lynch.
Antimicrobial resistance: It's time to reverse the trend.
Chest, 119 (2001), pp. 371S-372S
[8.]
J.P. Burke.
Infection control- A problem for patient safety.
N Engl J Med, 348 (2003), pp. 651-656
[9.]
C.A. Arias, J. Reyes, M. Zúñiga, L. Cortés, C. Cruz, C.L. Rico, et al.
The Colombian Antimicrobial Resistance group (RESCOL), multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001–2002.
J Antimicrob Chemother, 51 (2003), pp. 59-68
[10.]
P.L. Winokur, R. Canton, J.M. Casellas, N. Legakis.
Variations in the prevalence of strains expressing an extended-spectrum Blactamase phenotype and characterization of isolates from Europe, the Americas, and western pacific region.
Clin Infect Dis, 32 (2001), pp. S94-S103
[11.]
C. Bantar, B. Sartori, E. Vesco, C. Heft, M. Saúl, F. Salamone, M.E. Oliva.
A hospital wide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings and bacterial resistance.
Clin Infect Dis, 37 (2003), pp. 180-185
[12.]
D.L. Monnet.
ABC Calc, Antibiotic Consumption Calculator [Microsoft Excel application]. Version 3. 0.
Statens Serum Institut, (2005),
[13.]
M. Maxwell, D. Heaney, J.G. Howie, S. Noble.
General practice fundholding: Observations on prescribing patterns and costs using the defined daily dose method.
BMJ, 307 (1993), pp. 1190-1194
[14.]
A. Silver, A. Eichorn, J. Kral, G. Pickett, P. Barie, V. Pryor, et al.
Timeliness and use of antibiotic prophylaxis in selected inpatient surgical procedures.
Am J Surg, 171 (1996), pp. 548-552
[15.]
J.C. Cataño.
Impacto económico y ecológico del infectólogo en los hospitales.
Acta Med Colomb, 33 (2008), pp. 58-62
[16.]
H. Seppälä, T. Klaukka, J. Vuopio-Varkila, A. Muotiala, H. Helenius, K. Lager.
The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland.
N Engl J Med, 337 (1997), pp. 441-446
[17.]
C. Bantar, E. Vesco, C. Heft, F. Salamone, M. Krayeski, H. Gomez, et al.
Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance.
Antimicrob Agents Chemother, 48 (2004), pp. 392-395
[18.]
G. De Santis, K.J. Harvey, D. Howard, M.L. Mashford, R.F. Moulds.
Improving the quality of antibiotic prescription patterns in general practice. The role of educational intervention.
Med J Aust, 160 (1994), pp. 502-505
[19.]
I.C. Gyssens, W.L. Blok, P.J. van den Broek, Y.A. Hekster, J.W. van der Meer.
Implementation of an educational program and antibiotic order form to optimize of antimicrobial drugs use in a department of internal medicine.
Eur J Clin Microbiol Infect Dis, 16 (1997), pp. 904-912
[20.]
M.S. Niederman.
Appropriate use of antimicrobial agents: Challenges and strategies for improvement.
Crit Care Med, 31 (2003), pp. 608-616
Copyright © 2009. Asociación Colombiana de Infectología (ACIN)
Download PDF
Article options